 |
Depósito mínimo $50 Promoción exclusiva |
Nuestra puntuación |
Comisión 0% |
Are you looking to buy Merck & Co., Inc. stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:MRK! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Merck & Co., Inc. stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; Transcenta Holding Ltd.; and Janux Therapeutics, Inc. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Volumen medio
10.49 million shs
TAPA DEL MERCADO
$190.26 billion
Bolsa
NYSE
¡Compre esta acción!
|
NOMBRE
|
TICKER
|
INDUSTRIA
|
SECTOR
|
VOLUMEN
|
COMPRE ESTA ACCIÓN AHORA
|
|---|---|---|---|---|---|
|
NYSE:MRK
|
Preparados farmacéuticos
|
Médico
|
370,994 shs
|
Below is a quick guide on how to buy NYSE:MRK stocks safe, fast and around the world in less than five minutes.
Paso 1: Abrir una cuenta en eToro – eToro is the best broker to buy Merck & Co., Inc. shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Paso 2: Suba su identificación - Según las regulaciones de KYC, eToro le pedirá que suba una copia de su pasaporte o licencia de conducir.
Paso 3: Depositar los fondos - Deposite algo de dinero en su recién creada cuenta de eToro. Puede elegir entre transferencia bancaria, monedero electrónico o tarjeta de débito/crédito o Paypal.
Paso 4: Buy Merck & Co., Inc. – Search for “”NYSE:MRK”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Merck & Co., Inc. stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
15 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Merck & Co., Inc. in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Merck & Co., Inc. stock.
Wall Street analysts have given Merck & Co., Inc. a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Merck & Co., Inc. wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
2 |  | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
3 |  | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:MRK stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Merck & Co., Inc. stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Merck & Co., Inc. stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Debido a que eToro es una plataforma regulada, tendrá que completar el proceso KYC, esto es una práctica estándar y sólo toma un par de minutos. Tendrá que proporcionar un documento de identidad con fotografía (pasaporte, permiso de conducir) y un comprobante de domicilio (factura de servicios públicos, extracto bancario).
Una vez que se haya registrado y verificado su cuenta, deberá depositar fondos. eToro acepta tarjetas de crédito/débito, transferencias bancarias y también monederos electrónicos. Así que, sea cual sea su preferencia, habrá algo para usted.
Now that you’ve funded your eToro account, just type “NYSE:MRK stocks" en la barra de búsqueda de la parte superior de la pantalla y pulse "comercio".
All that’s left is to buy some NYSE:MRK stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:MRK is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Merck & Co., Inc. stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Merck & Co., Inc. is scheduled to release its next quarterly earnings announcement on Tuesday, April 27th 2021.
View our earnings forecast for Merck & Co., Inc..
Merck & Co., Inc. (NYSE:MRK) released its earnings results on Wednesday, February, 3rd. The company reported $1.32 EPS for the quarter, missing analysts’ consensus estimates of $1.38 by $0.06. The business earned $12.51 billion during the quarter, compared to analysts’ expectations of $12.65 billion. Merck & Co., Inc. had a net margin of 24.33% and a trailing twelve-month return on equity of 53.83%. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.16 EPS.
View Merck & Co., Inc.’s earnings history.
Merck & Co., Inc.’s stock was trading at $79.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MRK stock has decreased by 3.9% and is now trading at $76.13.
Merck & Co., Inc. declared a quarterly dividend on Wednesday, January 27th. Investors of record on Monday, March 15th will be given a dividend of $0.65 per share on Wednesday, April 7th. This represents a $2.60 dividend on an annualized basis and a dividend yield of 3.42%. The ex-dividend date is Friday, March 12th.
View Merck & Co., Inc.’s dividend history.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:MRK stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Más de 95% de los fondos de los clientes se mantienen fuera de línea, en almacenamiento en frío, lo que es crucial para cualquier corredor que gestione sus activos. Independientemente de lo segura que sea una plataforma, le recomendamos que utilice el sistema 2FA para añadir una capa adicional de seguridad a su cuenta.
eToro ofrece a los usuarios una serie de características para empezar a invertir lo antes posible. Tienen una característica relativamente única llamada copy trading, que le permite obtener un ingreso pasivo al imitar a operadores experimentados, esto le permite comenzar a obtener ganancias rápidamente, y le da una mejor comprensión de las estrategias utilizadas por los profesionales. Además, eToro permite a los usuarios invertir en carteras gestionadas, siendo una cartera gestionada una variedad de activos similares agrupados, lo que le permite diversificar su cuenta, reduciendo cualquier riesgo potencial. Para aquellos con experiencia previa en operaciones, puede invertir en mercados fuera de las acciones, ya que eToro permite a los usuarios operar con ETFs, materias primas, cripto e índices. Si ya invierte fuera del espacio bursátil, esto puede ser muy útil, ya que le permite gestionar todas sus inversiones en un solo lugar.
Merck & Co., Inc. pays an annual dividend of $2.60 per share and currently has a dividend yield of 3.43%. Merck & Co., Inc. does not yet have a strock track record of dividend growth. The dividend payout ratio of Merck & Co., Inc. is 50.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Merck & Co., Inc. will have a dividend payout ratio of 42.83% next year. This indicates that Merck & Co., Inc. will be able to sustain or increase its dividend.
View Merck & Co., Inc.’s dividend history.
Merck & Co., Inc. issued an update on its FY21 earnings guidance on Thursday, February, 4th. The company provided EPS guidance of $6-48-6.68 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.19. The company issued revenue guidance of $51.8-53.8 billion, compared to the consensus revenue estimate of $51.58 billion.
Los CFD son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento. 68% de las cuentas de inversores minoristas pierden dinero al operar con CFDs con este proveedor. Debe considerar si entiende cómo funcionan los CFD y si puede permitirse asumir el alto riesgo de perder su dinero.
15 brokerages have issued 12-month target prices for Merck & Co., Inc.’s stock. Their forecasts range from $88.00 to $105.00. On average, they anticipate Merck & Co., Inc.’s stock price to reach $95.36 in the next year. This suggests a possible upside of 25.3% from the stock’s current price.
View analysts’ price targets for Merck & Co., Inc. or view top-rated stocks among Wall Street analysts.
Merck & Co., Inc. saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 18,230,000 shares, an increase of 14.2% from the December 31st total of 15,970,000 shares. Based on an average trading volume of 9,070,000 shares, the days-to-cover ratio is presently 2.0 days. Approximately 0.7% of the company’s stock are short sold.
View Merck & Co., Inc.’s Short Interest.
Merck & Co., Inc.’s management team includes the following people:
Mr. Kenneth C. Frazier, Chairman, Pres & CEO (Age 66, Pay $6.64M)
Mr. Robert M. Davis, Exec. VP of Global Services & CFO (Age 54, Pay $3.29M)
Ms. Jennifer L. Zachary, Exec. VP, Gen. Counsel & Corp. Sec. (Age 43, Pay $2.47M)
Mr. Sanat Chattopadhyay, Exec. VP & Pres of Merck Manufacturing Division (Age 61, Pay $2.01M)
Mr. David Michael Williams, Chief Information & Digital Officer
Mr. Peter Dannenbaum CFA, VP of Investor Relations
Michael W. Fleming, Sr. VP and Chief Ethics & Compliance Officer (Age 62)
Ms. Jennifer Mauer, VP of Global Communications
Mr. Michael T. Nally, Chief Marketing Officer & Exec. VP (Age 45)
Mr. Steven C. Mizell, Exec. VP & Chief HR Officer (Age 61)
1,343 employees have rated Merck & Co., Inc. CEO Kenneth C. Frazier on Glassdoor.com. Kenneth C. Frazier has an approval rating of 94% among Merck & Co., Inc.’s employees. This puts Kenneth C. Frazier in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
1 | | Depósito mínimo $50 Promoción exclusiva | Nuestra puntuación 10 ★★★★★ | Comisión 0% |
Some companies that are related to Merck & Co., Inc. include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of MRK’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Merck & Co., Inc. investors own include Pfizer (PFE), Johnson & Johnson (JNJ), AT&T (T), Intel (INTC), Cisco Systems (CSCO), The Walt Disney (DIS), Verizon Communications (VZ), JPMorgan Chase & Co. (JPM), AbbVie (ABBV) and The Home Depot (HD).
Merck & Co., Inc. trades on the New York Stock Exchange (NYSE) under the ticker symbol “MRK.”
Merck & Co., Inc.’s stock is owned by a variety of institutional and retail investors. Top institutional shareholders include California Public Employees Retirement System (0.54%), Swiss National Bank (0.42%), Fisher Asset Management LLC (0.38%), Sumitomo Mitsui Trust Holdings Inc. (0.37%), Robeco Institutional Asset Management B.V. (0.17%) and Bahl & Gaynor Inc. (0.15%). Company insiders that own Merck & Co., Inc. stock include Frank Clyburn, Julie L Gerberding, Kenneth C Frazier, Leslie A Brun, Merck & Co, Inc, Richard R Deluca, Rita A Karachun, Robert M Davis, Sanat Chattopadhyay and Wendell P Weeks.
View institutional ownership trends for Merck & Co., Inc..
MRK stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Sumitomo Mitsui Trust Holdings Inc., AJO LP, Capital Wealth Planning LLC, Ceredex Value Advisors LLC, Ninety One UK Ltd, GWM Advisors LLC, and Gateway Investment Advisers LLC. Company insiders that have sold Merck & Co., Inc. company stock in the last year include Frank Clyburn, Julie L Gerberding, Robert M Davis, Sanat Chattopadhyay, and Wendell P Weeks.
View insider buying and selling activity for Merck & Co., Inc. or view top insider-selling stocks.
MRK stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Alecta Pensionsforsakring Omsesidigt, Russell Investments Group Ltd., Candriam Luxembourg S.C.A., Robeco Institutional Asset Management B.V., KAMES CAPITAL plc, Marathon Asset Management LLP, and Value Partners Investments Inc..
View insider buying and selling activity for Merck & Co., Inc. or or view top insider-buying stocks.
En Reportlab.org queremos asegurarnos de que tenga toda la información más relevante sobre compra de acciones. Le ofrecemos las mejores guías sobre el mercado de valores con reseñas personales, información de fondo, reseñas de las plataformas, instrucciones y mucho más. ¿Quiere obtener otra información? Entonces consulte la Acciones OTC, Acciones del NASDAQ, Acciones de la Bolsa de Valores de Nueva York, Acciones LON, Acciones de la FRA, Acciones ETR, Reservas de la EPA, Acciones del TSX o Acciones Amex. Buscando información más detallada como 5g de existencias, acciones de biotecnología, acciones de oro y otra información de nuestro laboratorio de informes.
How to buy Merck & Co., Inc. stocks?
The safest and easiest way to buy NYSE:MRK stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Abrir una cuenta con uno de estos brokers es una decisión inteligente, llevan más de 10 años en activo, son muy seguros de usar y tienen la mejor plataforma para traders novatos y experimentados. Si quiere saber más, le sugerimos que lea nuestro eToro o DeGiro guías.
Where to buy Merck & Co., Inc. stock?
You will first want to find a licensed broker that supports Merck & Co., Inc. stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:MRK stocks in a safe and complete environment.
Is NYSE:MRK stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:MRK stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Merck & Co., Inc. stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:MRK is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Merck & Co., Inc. stock.
How do you trade Merck & Co., Inc. stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Merck & Co., Inc. stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:MRK stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Merck & Co., Inc. stock?
To sell your NYSE:MRK stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Merck & Co., Inc. stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:MRK stock.
Stephen sabe mucho sobre productos financieros y, en particular, tiene una gran pasión por los mercados de valores y sus participantes. Esperamos que la información proporcionada le sirva de ayuda. ¿Hay algo que no está claro? Deje sus preguntas o comentarios al final de la página.
| Nuestra puntuación ★★★★★ | |
| Nuestra puntuación ★★★★★ | |
| Nuestra puntuación ★★★★★ |
Boletín de noticias
Noticias recientes
| |
Nuestra puntuación |
Comisión 0% |
Datos de acciones y criptografía en tiempo real
Notificaciones, consejos y noticias
Las mejores guías sobre acciones y criptografía
Reseñas sobre el corredor y la bolsa en línea
Reportlab Finanzas es una página web puramente informativa y en ningún caso implica un asesoramiento de inversión. Todas las inversiones conllevan riesgos y usted puede perder todas sus inversiones. No invierta dinero que no pueda permitirse perder.
Reportlab Finanzas
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos los derechos reservados.
